Abstract:Cutting off the glucose supply by glucose oxidase (GOx) has been regarded as an emerging strategy in cancer starvation therapy. However, the standalone GOx delivery suffered suboptimal potency for tumor elimination and potential risks of damaging vasculatures and normal organs during transportation. To enhance therapeutic efficacy and tumor specificity, a site-specific activated dual-catalytic nanoreactor was herein constructed by embedding GOx and ferrocene in hyaluronic acid (HA)-enveloped dendritic mesoporous silica nanoparticles to promote intratumoral oxidative stress in cancer starvation. In this nanoreactor, the encapsulated GOx served as the primary catalyst that accelerated oxidation of glucose and generation of H2O2, while the covalently linked ferrocene worked as the secondary catalyst for converting the upstream H2O2 to more toxic hydroxyl radicals (•OH) via a classic Fenton reaction. The outmost HA shell not only offered a shielding layer for preventing blood glucose from oxidation during nanoreactor transportation, thus minimizing the probable oxidative damage to normal tissues, but also imparted the nanoreactor with targeting ability for facilitating its internalization into CD44-overexpressing tumor cells. After the nanoreactor was endocytosed by target cells, the HA shell underwent hyaluronidase-triggered degradation in lysosomes and switched on the cascade catalytic reaction mediated by GOx and ferrocene. The resulting glucose exhaustion and •OH accumulation would effectively kill cancer cells and suppress tumor growth via combination of starvation and oxidative stress enhancement. Both in vitro and in vivo results indicated the significantly amplified therapeutic effects of this synergistic therapeutic strategy based on the dual-catalytic nanoreactor. Our study provides a new avenue for engineering therapeutic nanoreactors that take effect in a tumor-specific and orchestrated fashion for cancer starvation therapy.

Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works

Engineering dual catalytic nanomedicine for autophagy-augmented and ferroptosis-involved cancer nanotherapy

Nanozyme for tumor therapy: Surface modification matters

Multifunctional RGD Coated a Single-Atom Iron Nanozyme: A Highly Selective Approach to Inducing Ferroptosis and Enhancing Immunotherapy for Pancreatic Cancer

Dual isolated bimetal single-atom catalysts for tumor ROS cycle and parallel catalytic therapy

Synergistic ROS Generation via Core-Shell Nanostructures with Increased Lattice Microstrain Combined with Single-Atom Catalysis for Enhanced Tumor Suppression

Synergistic Effect of SiO2 and Fe3O4 Nanoparticles in Autophagy Modulation

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Self-cascade catalytic single-atom nanozyme for enhanced breast cancer low-dose radiotherapy

Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.

Cascaded Nanozyme with In‐Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy

Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy

Multifaceted Elevation of ROS Generation for Effective Cancer Suppression

Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer

Boosting Tumor Apoptosis and Ferroptosis with Multienzyme Mimetic Au Single‐Atom Nanozymes Engaged in Cascade Catalysis

Nanoscale Dual-Enzyme Cascade Metal-Organic Frameworks Through Biomimetic Mineralization As ROS Generators for Synergistic Cancer Therapy.

Single Atom‐Engineered 2D Catalytic Nanosheets for Sonocatalytic Suppression of Orthotopic Clear Cell Renal Cell Carcinoma

Nanomedicine for cancer targeted therapy with autophagy regulation

Fe-based cyclically catalyzing double free radical nanogenerator for tumor-targeted chemodynamic therapy

A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress

Self-cycling redox nanoplatform in synergy with mild magnetothermal and autophagy inhibition for efficient cancer therapy